[topsearch__bar__shortcode]

September 28, 2021

Crown ElectroKinetics Corp. (CRKN) Stock Surged 6.15% Today, Here’s Why 

Leave a Comment / Featured, Mid Day Movers /

Crown ElectroKinetics Corp. (CRKN) stock soared 6.15% in the current-market trading session at the price of $3.61 after it signed its first commercial customer agreement with MetroSpaces, Inc. CRKN is a leading glass technology company. Its technology enables the glass surface to transition between clear and dark within seconds and is appropriate for commercial buildings, automotive sunroofs, […]

Crown ElectroKinetics Corp. (CRKN) Stock Surged 6.15% Today, Here’s Why  Read More »

Sonoma Pharmaceuticals, Inc. (SNOA) Stock Surged 38.79% Current-Market, Here’s Why  

Leave a Comment / Featured, Mid Day Movers /

Sonoma Pharmaceuticals, Inc. (SNOA) stock soared 38.79% in the current-market trading session at the price of $7.42 after the company launched its first over-the-counter products on Amazon in the U.S and Europe. SNOA is a leading global healthcare company. It develops and commercializes stabilized hypochlorous acid (HOCl) products for a broad range of health care treatments. 

Sonoma Pharmaceuticals, Inc. (SNOA) Stock Surged 38.79% Current-Market, Here’s Why   Read More »

Lets find out whats hot about HUMBL, Inc. (OTC Markets: HMBL)

Leave a Comment / Mid Day Movers /

HMBL stock closed down -5.16% to $0.8249 at the previous close. The company’s average volume is recorded at 4,714,147 shares changing hands. The only news reported about the company was on Sept. 24, 2021, when HUMBL, Inc. (OTC Markets: HMBL) announced Peter M Schulte has been joined by the HUMBL Board of Directors as an

Lets find out whats hot about HUMBL, Inc. (OTC Markets: HMBL) Read More »

New Concept Energy, Inc. (GBR) Stock Enjoying a Bullish Sentiment in Premarket

Leave a Comment / Featured, Market News /

New Concept Energy, Inc. (GBR), a company engaged in the oil and gas business, has increased by 5.26% in the premarket trading session. Consequently, GBR stock was trading at $5.60 when last checked. On Monday, GBR stock closed the day at $5.32 after skyrocketing 31.36% during regular trading hours. There appears to be no specific news

New Concept Energy, Inc. (GBR) Stock Enjoying a Bullish Sentiment in Premarket Read More »

NeuroBo Pharmaceuticals, Inc. (NRBO) Stock Surging in Premarket

Leave a Comment / Market News /

NeuroBo Pharmaceuticals, Inc. (NRBO), a clinical-stage biotechnology company, has seen an increase of 8.73% in the premarket trading session. As a result, NRBO stock was trading at $4.11 when last checked. There appears to be no certain reason for this increase in NRBO stock. On Monday, NRBO stock closed the day at $3.78 after declining

NeuroBo Pharmaceuticals, Inc. (NRBO) Stock Surging in Premarket Read More »

Altimmune, Inc. (ALT) Stock Surged 0.92% Pre-Market, Here’s Why   

Leave a Comment / Featured, Morning News /

Altimmune, Inc. (ALT) stock soared 0.92% in the pre-market trading session at the price of $15.33 after it scheduled to report a 12-week Phase 1 clinical trial results of its ALT-801 on 28th September 2021. ALT is a clinical-stage biopharmaceutical company. It develops and commercializes therapies to treat obesity and liver diseases. NASH (ALT-801), a

Altimmune, Inc. (ALT) Stock Surged 0.92% Pre-Market, Here’s Why    Read More »

Ocuphire Pharma, Inc. (OCUP) Stock Plunged 3.16% After-Hours, Here’s Why  

Leave a Comment / Featured, Morning News /

Ocuphire Pharma, Inc. (OCUP) stock plummeted 3.16% in the after-hours trading session at the price of $5.21 following the announcement of participation in three upcoming healthcare conferences. OCUP is a clinical-stage ophthalmic biopharmaceutical company. It produces and commercializes therapies to treat various eye disorders. The company’s pipeline comprises two small-molecule product candidates that target the front and

Ocuphire Pharma, Inc. (OCUP) Stock Plunged 3.16% After-Hours, Here’s Why   Read More »

ZIOPHARM Oncology, Inc. (ZIOP) Stock Plunged 18.40% After-Hours, Here’s Why 

Leave a Comment / Featured, Morning News /

ZIOPHARM Oncology, Inc. (ZIOP) stock plummeted 18.40% in the after-hours trading session at the price of $1.73 following the announcement of a strategic deduction in the workforce and expansion in the cash runway. ZIOP is a leading immuno-oncology platform. It produces cytokine-driven cells and gene therapies to weaponize the human immune system to treat people diagnosed

ZIOPHARM Oncology, Inc. (ZIOP) Stock Plunged 18.40% After-Hours, Here’s Why  Read More »

Stocks
Telegraph

At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.

About

Categories

Social Links

Facebook Twitter Youtube Instagram Linkedin